Debolina Dasgupta

Also affiliated with The University of Kansas Cancer Center, University of Kansas Medical Center

EngineeringChemical EngineeringBiochemistry, Genetics and Molecular BiologyEarth and Planetary SciencesEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells”.

Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells

ImmunoHorizons(2023)10.4049/immunohorizons.2200061

N/A

0DataRank · unranked

25 citations

Debolina Dasgupta, Aprajita Tripathi, Kalyani Pyaram, Anil Pant

Cadmium-induced lung injury disrupts immune cell homeostasis in the secondary lymphoid organs in mice

Toxicology(2024)10.1016/j.tox.2024.153971

N/A

0DataRank · unranked

7 citations

Debolina Dasgupta, Aprajita Tripathi, Nicolas Steele, Kalyani Pyaram, Isaac K. Sundar +1 more

Nrf2 regulates the activation-driven expansion of CD4 + T-cells by differentially modulating glucose and glutamine metabolism

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.18.590146

N/A

0DataRank · unranked

2 citations

Debolina Dasgupta, Anil Pant, Ashlyn Bugbee, Nanda Kumar Yellapu, Ben H. Choi +3 more

Nrf2 drives activation-driven expansion of CD4+T cells by modulating glucose and glutamine metabolism

Cell Reports(2025)10.1016/j.celrep.2025.116177

N/A

0DataRank · unranked

6 citations

Debolina Dasgupta, Michael S. Dahabieh, Rachel Griffard, Anil Pant, Ashlyn Bugbee +11 more

Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel disease

The Journal of Immunology(2025)10.1093/jimmun/vkaf117

N/A

0DataRank · unranked

4 citations

Aprajita Tripathi, Rachel Griffard, Nanda Kumar Yellapu, Poojaben Dhorajiya, Kalyani Pyaram +1 more

Nrf2 as a negative regulator of CD8+ T-Cell-mediated anti-melanoma responses 3613

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1393

N/A

0DataRank · unranked

0 citations

Aprajita Tripathi, Debolina Dasgupta, Kalyani Pyaram, Nadine Santana Magal